Here are five key takeaways:
1. Analytik Jena AG has years of experience in creating in vitro diagnostic assays such as diagnostics for hepatitis B and C.
2. The company’s kit is a major innovation in the standardization of HDV nucleic acid amplification test.
3. Hepatitis D often leads to chronic cirrhosis of the liver in cases of superinfection, making the kit an important tool for detecting the virus.
4. The virus mainly occurs in the Mediterranean area, the Middle East, South and Central Asia, West Africa and the Amazon region of South America.
5. The company is currently working to adapt the kit to Analytik Jena’s current automation platforms.
More articles on quality & infection control:
The infection-reducing robot — 5 things to know about Xenex’s germ-killing device
Identification Systems Group to improve patient safety with wristbands: 4 points
5 notes about a new coalition tackling diagnostic errors
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
